Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 298
Filtrar
1.
Int J Pediatr Otorhinolaryngol ; 183: 112051, 2024 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-39084101

RESUMEN

OBJECTIVES: This study aims to determine the overall incidence of medical and surgical admissions related to non-tuberculous mycobacterial cervicofacial lymphadenitis (NTMCL) and determine if rates vary by geographic region in the US. It also aims to assess if the relative frequency of varying treatment modalities for NTMCL differ among geographic regions. STUDY DESIGN: Population-based inpatient registry analysis. SETTING: Academic medical center. METHODS: The Kids' Inpatient Database (2016 and 2019) was used to determine NTMCL-related admissions and common head and neck procedures performed during these admissions were identified. Analysis was performed on regional differences in demographic factors and procedures performed during NTMCL-related admissions. RESULTS: There were 159 weighted admissions (1.31 per 100,000) for NTMCL in 2016 and 2019 in the US, with the Midwest having the highest proportion of NTML-related admissions (1.59:100,000). NTMCL-related admissions were 2.21 times as likely to be elective rather than non-elective in the Midwest when compared to all other geographic regions (p = 0.038). The Midwest was 2.83 times as likely to treat with surgery (p = 0.011), while the Northeast was negatively associated with performing procedures (OR 0.38; p = 0.026). In the Midwest, significantly more excisional surgeries were preformed when compared to other regions, with an OR of 2.98 (p = 0.003). CONCLUSION: The Midwest had the highest incidence of pediatric NTMCL-related admissions and was more likely to perform excisional surgery as primary NTMCL treatment. Regions that rarely see pediatric NTMCL have a more inconsistent approach to management.


Asunto(s)
Linfadenitis , Infecciones por Mycobacterium no Tuberculosas , Humanos , Infecciones por Mycobacterium no Tuberculosas/cirugía , Infecciones por Mycobacterium no Tuberculosas/epidemiología , Masculino , Niño , Femenino , Linfadenitis/cirugía , Linfadenitis/epidemiología , Linfadenitis/microbiología , Preescolar , Estados Unidos , Adolescente , Cuello/cirugía , Incidencia , Lactante , Sistema de Registros , Hospitalización/estadística & datos numéricos , Estudios Retrospectivos , Micobacterias no Tuberculosas/aislamiento & purificación
2.
Prev Vet Med ; 230: 106278, 2024 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-39003836

RESUMEN

A large-scale study was carried out in the Polish goat population in 2014-2021 to determine the herd-level true seroprevalence (HTP) of caseous lymphadenitis (CLA) caused by Corynebacterium pseudotuberculosis (Cp) and paratuberculosis (PTB) caused by Mycobacterium avium ssp. paratuberculosis (Map). Two-stage cluster sampling was applied to herds counting at least 20 adult goats (aged >1 year) and in each herd all males and 10-13 females were tested. At least one seropositive goat regardless of its sex was necessary to consider the herd as infected. HTP was estimated using the Bayesian approach with the Gibbs sampler in the EpiTools and reported as the median and 95 % credibility interval (95 % CrI). A total of 1282 adult goats from 86 herds were serologically tested using two commercial ELISAs (Cp-ELISA and Map-ELISA). At least 1 seropositive result of Cp-ELISA and Map-ELISA was obtained in 73/86 herds (84.9 %) and 40/86 herds (46.5 %), respectively. HTP of CLA was estimated at 73.3 % (95 % CrI: 65.0 %, 80.4 %) and HTP of PTB was estimated at 42.9 % (95 % CrI: 25.8 %, 58.0 %). There was a significant positive association between the occurrence of CLA and PTB in the herds (odds ratio 6.0, 95 % confidence interval: 1.2, 28.8; p = 0.010). Probability of the seropositive result for PTB was also significantly higher in Cp-seropositive goats than in Cp-seronegative goats (odds ratio 3.9, 95 % confidence interval: 2.4, 6.3; p < 0.001) which could indicate either a higher risk of co-infection or a higher rate of false positive results for PTB in Cp-positive goats. To investigate this issue, optical densities obtained in Map-ELISA were compared between Cp-positive and Cp-negative goats and results of Map-ELISA were adjusted accordingly. Map-negative sera from Cp-positive goats turned out to have significantly higher optical densities than Map-negative sera from Cp-negative goats (p < 0.001). After the adjustment, the herd-level apparent seroprevalence of PTB was 41.9 % (36/86 herds) so it still fell within the 95 % CrI of HTP of PTB calculated before the adjustment. Concluding, CLA appears to be widespread in the Polish goat population. In many of them it may be subclinical at the moment, however will likely emerge in the future as the disease follows cyclic pattern in Poland. On the other hand, given the total lack of clinical PTB in Polish goats, an explanation for a high HTP of PTB remains unclear and warrants further studies using tests of higher analytical specificity than ELISA.


Asunto(s)
Corynebacterium pseudotuberculosis , Ensayo de Inmunoadsorción Enzimática , Enfermedades de las Cabras , Cabras , Mycobacterium avium subsp. paratuberculosis , Paratuberculosis , Animales , Paratuberculosis/epidemiología , Paratuberculosis/sangre , Paratuberculosis/microbiología , Estudios Seroepidemiológicos , Enfermedades de las Cabras/epidemiología , Enfermedades de las Cabras/microbiología , Enfermedades de las Cabras/sangre , Polonia/epidemiología , Mycobacterium avium subsp. paratuberculosis/aislamiento & purificación , Corynebacterium pseudotuberculosis/aislamiento & purificación , Femenino , Masculino , Ensayo de Inmunoadsorción Enzimática/veterinaria , Infecciones por Corynebacterium/veterinaria , Infecciones por Corynebacterium/epidemiología , Infecciones por Corynebacterium/microbiología , Linfadenitis/veterinaria , Linfadenitis/epidemiología , Linfadenitis/microbiología , Teorema de Bayes , Prevalencia
3.
Int J Pediatr Otorhinolaryngol ; 182: 112019, 2024 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-38944979

RESUMEN

OBJECTIVE: Cervicofacial lymphadenitis caused by non-tubercular mycobacterial (NTM) infections has the highest infection rate in children. Our objective was to assess patient demographics, treatment methods, and the impact of weather and geography on the incidence of disease in patients with NTM cervicofacial lymphadenitis. METHODS: The Pediatric Health Information System (PHIS) database was queried for data on all patients diagnosed with concurrent cervicofacial lymphadenopathy and NTM infection from 2004 to 2022. We assessed the association between weather patterns and NTM cervicofacial lymphadenitis by collecting monthly weather data from the NOAA National Center for Environmental Information. Incidence rates were calculated by dividing the number of cases by the total hospital discharges during the study period. RESULTS: Among 47 PHIS hospitals, there were 992 diagnoses of NTM cervicofacial lymphadenitis. The average age at diagnosis was 2 [IQR, 2-4], with 59 % female. Drainage of skin abscesses or lesions was performed for 93 (9.4 %) patients, while 15 (1.5 %) had an excisional procedure of the CPT codes assessed. The most common antibiotics utilized were cephalosporins (28 %), macrolides (27 %), and rifampin (12 %). The most common treatment method was surgery with antibiotics (37 %) followed by no treatment at all (35 %), surgery alone (17 %), and antibiotics alone (10 %). Of the 28 states included in the analysis, Washington (IR: 3.5) and Nebraska (IR: 3.3) had the highest incidence rates (IR) of NTM cervical lymphadenitis. The cases were relatively equally distributed across the different weather seasons within each U.S. geographic region. However, the overall average wind speed was weakly associated with increasing the risk of diagnosis when utilizing a mixed effect zero-inflated negative binomial model (Incidence Ratio: 1.07, 95 % CI: (1.01-1.14), p = 0.035). CONCLUSIONS: Our results indicate that the most common treatment method utilized in patients within our cohort with NTM cervicofacial lymphadenitis was the concurrent use of surgery and antibiotics. Our results also indicate there may be variation in the incidence rate among different states, but additional studies are needed as our cohort only included approximately 50 % of states within the U.S.


Asunto(s)
Bases de Datos Factuales , Linfadenitis , Infecciones por Mycobacterium no Tuberculosas , Humanos , Femenino , Infecciones por Mycobacterium no Tuberculosas/epidemiología , Infecciones por Mycobacterium no Tuberculosas/terapia , Infecciones por Mycobacterium no Tuberculosas/diagnóstico , Masculino , Linfadenitis/epidemiología , Linfadenitis/microbiología , Linfadenitis/terapia , Preescolar , Incidencia , Estados Unidos/epidemiología , Antibacterianos/uso terapéutico , Cuello/microbiología , Cara , Niño , Estudios Retrospectivos , Micobacterias no Tuberculosas/aislamiento & purificación , Lactante
4.
Pediatr Rheumatol Online J ; 22(1): 55, 2024 May 17.
Artículo en Inglés | MEDLINE | ID: mdl-38760816

RESUMEN

BACKGROUND: Systemic autoinflammatory disorders (SAIDs) represent a growing spectrum of diseases characterized by dysregulation of the innate immune system. The most common pediatric autoinflammatory fever syndrome, Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis (PFAPA), has well defined clinical diagnostic criteria, but there is a subset of patients who do not meet these criteria and are classified as undefined autoinflammatory diseases (uAID). This project, endorsed by PRES, supported by the EMERGE fellowship program, aimed to analyze the evolution of symptoms in recurrent fevers without molecular diagnosis in the context of undifferentiated AIDs, focusing on PFAPA and syndrome of undifferentiated recurrent fever (SURF), using data from European AID registries. METHODS: Data of patients with PFAPA, SURF and uSAID were collected from 3 registries including detailed epidemiological, demographic and clinical data, results of the genetic testing and additional laboratory investigations with retrospective application of the modified Marshall and PRINTO/Eurofever classification criteria on the cohort of PFAPA patients and preliminary SURF criteria on uSAID/SURF patients. RESULTS: Clinical presentation of PFAPA is variable and some patients did not fit the conventional PFAPA criteria and exhibit different symptoms. Some patients did not meet the criteria for either PFAPA or SURF, highlighting the heterogeneity within these groups. The study also explored potential overlaps between PFAPA and SURF/uAID, revealing that some patients exhibited symptoms characteristic of both conditions, emphasizing the need for more precise classification criteria. CONCLUSIONS: Patients with recurrent fevers without molecular diagnoses represent a clinically heterogeneous group. Improved classification criteria are needed for both PFAPA and SURF/uAID to accurately identify and manage these patients, ultimately improving clinical outcomes.


Asunto(s)
Enfermedades Autoinflamatorias Hereditarias , Linfadenitis , Faringitis , Sistema de Registros , Estomatitis Aftosa , Humanos , Niño , Europa (Continente)/epidemiología , Femenino , Masculino , Estomatitis Aftosa/diagnóstico , Estomatitis Aftosa/epidemiología , Preescolar , Enfermedades Autoinflamatorias Hereditarias/diagnóstico , Linfadenitis/diagnóstico , Linfadenitis/epidemiología , Faringitis/diagnóstico , Adolescente , Lactante , Estudios Retrospectivos , Fiebre/etiología , Fiebre/diagnóstico , Recurrencia
5.
Eur Arch Otorhinolaryngol ; 281(3): 1463-1471, 2024 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-38085303

RESUMEN

PURPOSE: We aim to compare the different treatment modalities of non-tuberculous cervicofacial lymphadenitis in children, by means of a retrospective study conducted in the University Hospitals of Leuven of patients treated between 2012 and 2022. METHODS: For this retrospective cohort study, data were collected and pseudonimised from 52 patients with non-tuberculous cervicofacial lymphadenitis, who were treated in our hospital between January 2012 and December 2022, either conservatively, antibiotically, surgically, or with a combination of these options. We only included patients who were considered immunocompetent. All of the included patients were below 10 years at time of treatment. We collected data regarding time to resolution and adverse effects, i.e., skin discoloration, excessive scar formation, fistula formation, persistence of adenopathies after treatment, need for additional treatment, facial nerve paresis/paralysis, or systemic side-effects due to antibiotic treatment. RESULTS: The mean time to resolution (in days) when looking at primary treatments, was shortest in partial excisions (16), followed by complete excisions (19), antibiotic therapy (129), incision and drainage (153), curettage (240), and finally conservative management (280). Taking into account isolated treatments (i.e., both primary and adjuvant), we also observed consistently faster time to resolution in surgical and antibiotic treatments when compared to conservative treatment. Antibiotic therapy (p = 0.003), incision and drainage (p = 0,004) were associated with a significantly higher need for adjuvant treatment. Curettage was associated with a higher incidence of fistula formation (p = 0,006) and higher number of adjuvant treatments (p = 0,002). CONCLUSIONS: This study shows a faster resolution of nontuberculous mycobacterial cervicofacial lymphadenitis in children when treated surgically, more specifically when treated with partial or complete lymph node excision. Antibiotic treatment also leads to faster resolution than conservative management. There was a low rate of complications, and no permanent facial nerve damage was reported.


Asunto(s)
Parálisis Facial , Fístula , Linfadenitis , Infecciones por Mycobacterium no Tuberculosas , Niño , Humanos , Lactante , Micobacterias no Tuberculosas , Estudios Retrospectivos , Linfadenitis/terapia , Linfadenitis/epidemiología , Linfadenitis/microbiología , Antibacterianos/uso terapéutico , Parálisis Facial/terapia , Parálisis Facial/tratamiento farmacológico , Infecciones por Mycobacterium no Tuberculosas/epidemiología , Infecciones por Mycobacterium no Tuberculosas/cirugía
6.
Open Vet J ; 13(5): 588-598, 2023 05.
Artículo en Inglés | MEDLINE | ID: mdl-37304616

RESUMEN

Background: Caseous lymphadenitis (CLA) is a chronic suppurative bacterial infection caused by Corynebacterium pseudotuberculosis (C. pseudotuberculosis) affecting superficial and internal lymph nodes and internal organs of small ruminants. Aims: Through the use of molecular methods, this study aimed to estimate the prevalence of CLA and its contributing factors as well as the degree of genetic diversity and epidemiological relationships among C. pseudotuberculosis isolates from slaughtered sheep and goats in various districts of Duhok Province, Iraq. Methods: A total of 18,836 carcasses (15,775 sheep and 3,061 goats) were inspected by veterinarians at slaughterhouses [Duhok-Sumel (2,453 sheep + 627 goats), Zakho (6,000 sheep), Bardarash (1,117 sheep + 379 goats), Amedi (413 sheep + 178 goats) and Akre (5,792 sheep + 1,877 goats)] in Duhok Province for detection the prevalence rate of CLA using molecular techniques. Results: The prevalence of the disease was 0.94% and 1.93% in sheep and goats, respectively. Sheep in Duhok-Sumel and goats in Amedi were at a higher risk of infection than the animals in another location, with a prevalence rate of 4.31% and 6.18%, respectively. Sheep and goats of older age were more susceptible. Females were more susceptible than males in all districts except Duhok-Sumel where the reverse was true. ERIC-PCR analysis grouped the bacterial isolates into 11 different genotypes. The maximum likelihood phylogenetic tree of partial sequences of the 16S rRNA gene sequences of C. pseudotuberculosis revealed no divergent sequences discovered in this study. Conclusion: A strict control program needs to be applied to reduce the entrance of pathogen from neighboring countries.


Asunto(s)
Enfermedades de las Cabras , Linfadenitis , Enfermedades de las Ovejas , Femenino , Masculino , Ovinos , Animales , Cabras , Epidemiología Molecular , Irak/epidemiología , Filogenia , ARN Ribosómico 16S , Linfadenitis/epidemiología , Linfadenitis/veterinaria , Enfermedades de las Cabras/epidemiología , Enfermedades de las Ovejas/epidemiología
7.
J Pediatric Infect Dis Soc ; 12(7): 406-412, 2023 Jul 31.
Artículo en Inglés | MEDLINE | ID: mdl-37310690

RESUMEN

BACKGROUND: Lymphadenitis is the most common manifestation of non-tuberculous mycobacteria (NTM) infection in children. We describe the epidemiology and clinical characteristics of NTM lymphadenitis, determine diagnostic yield from tissue sampling, and review management and outcomes. METHODS: This was a 10-year retrospective review of children aged 0-16 years diagnosed with NTM cervicofacial lymphadenitis who were seen in a pediatric infectious disease clinic in a tertiary public hospital. Data relating to patient demographics, clinical features, surgical and antimicrobial treatment, complications, and outcomes were retrieved from patients' electronic medical records and analyzed. RESULTS: There were 48 episodes of NTM cervicofacial lymphadenitis in 45 children (17 males and 28 females). Of these episodes, 43.7% manifested as a unilateral single node, mostly parotid (39.6%) and submandibular (29.2%). All patients underwent diagnostic fine-needle aspiration or surgery. Surgical excision more frequently yielded positive histological findings (P = .016). NTM was identified in 22/48 episodes (45.8%) via culture or molecular sequencing. Mycobacterium abscessus was most commonly found (47.8%). Thirty-eight children (79.2%) received antibiotics. Outcomes in 43 episodes revealed full resolution in 69.8%, while 25.6% had de novo disease and 4.6% experienced recurrence at the same site. Overlying skin changes and multiple or bilateral nodal diseases were significantly associated with de novo disease or recurrence (P = .034 and .084, respectively). Complications occurred in 11/70 (15.7%) procedures. Antibiotic-associated adverse effects occurred in 14/38 (36.8%) episodes. CONCLUSIONS: NTM lymphadenitis remains a challenging condition. More aggressive management with surgical excision and antibiotics is recommended for those with overlying skin changes and extensive nodal disease.


Asunto(s)
Linfadenitis , Infecciones por Mycobacterium no Tuberculosas , Masculino , Femenino , Niño , Humanos , Lactante , Micobacterias no Tuberculosas , Infecciones por Mycobacterium no Tuberculosas/diagnóstico , Infecciones por Mycobacterium no Tuberculosas/tratamiento farmacológico , Infecciones por Mycobacterium no Tuberculosas/epidemiología , Cuello , Linfadenitis/epidemiología , Linfadenitis/tratamiento farmacológico , Linfadenitis/microbiología , Antibacterianos/uso terapéutico
8.
Indian J Tuberc ; 70(2): 162-167, 2023 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-37100572

RESUMEN

BACKGROUND: This article is to review cervical lymphadenitis due to tuberculosis (TB), their presentation, their aetiology, the methods used to diagnose them, the treatment modalities offered and the response to treatment. METHODS: 1019 patients were diagnosed and treated for TB of the lymph nodes of the neck from 1st November 2001 to 31st August 2020 at a tertiary ENT hospital, Nadiad, Gujarat, India. Study consisted about 61% males and 39% females with the mean age being 37.3 years. RESULT: Commonest factor or habit among those diagnosed for tuberculous cervical lymphadenitis was consumption of unpasteurized milk. HIV and diabetes were the most common co-morbid conditions found with this disease. Swelling in the neck was most common clinical feature followed by loss of weight, formation of abscess, fever and fistula. Rifampicin resistance was found in 1.5% of patients among those tested for the same. CONCLUSION: The most commonly affected site for extra pulmonary TB is posterior triangle of neck than the anterior triangle. Patients with HIV and diabetes are at higher risk for the same. Testing for drug susceptibility has to be done due to increased resistant of drugs for extra pulmonary TB. GeneXpert and histopathological examination are important for its confirmation.


Asunto(s)
Infecciones por VIH , Linfadenitis , Tuberculosis Ganglionar , Masculino , Femenino , Humanos , Adulto , Estudios Retrospectivos , Tuberculosis Ganglionar/diagnóstico , Tuberculosis Ganglionar/tratamiento farmacológico , Tuberculosis Ganglionar/epidemiología , Ganglios Linfáticos/patología , Linfadenitis/epidemiología , Linfadenitis/patología , Infecciones por VIH/complicaciones , Infecciones por VIH/epidemiología
9.
Indian J Tuberc ; 69(4): 596-601, 2022 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-36460395

RESUMEN

INTRODUCTION: Bacillus Calmette-Guerin (BCG) vaccination is given as a part of the national immunization schedule in India and its most common complication is BCG lymphadenitis. The reported incidence of BCG lymphadenitis ranges from 0.1 to 9.9% in various studies. In our country, though most babies get BCG vaccination during the neonatal period, the incidence of BCG lymphadenitis is not studied well. AIMS: To study the incidence of lymphadenitis following BCG vaccination at tertiary care hospital in North India. METHODS: It was a prospective longitudinal observational study. All newborns weighing ≥1.5 kg at birth without any significant illness who received BCG vaccination at our institute were enrolled and followed up for 16 weeks after vaccination. Babies were examined at 6, 10 and 14 weeks for the development of lymphadenopathy. Meta-analysis of studies evaluating incidence of BCG adenitis in children was also performed. RESULTS: Out of 817 babies vaccinated during the enrolment period, 605 babies could be followed up till 16.2 ± 0.9 weeks post BCG vaccination. One case of BCG lymphadenitis was detected at 14 weeks. Thus, the observed incidence of BCG lymphadenitis was 0.16% (95% CI of 0.004%-0.92%). Meta-analysis of 21 studies showed mean incidence estimate of 0.336% (95% CI: 0.315%-0.358%) using fixed effect model whereas random effect model showed mean incidence of 4.45% (95% CI: 3.02%-6.15%). CONCLUSION: The lower incidence of lymphadenitis in our study can probably be attributed to a less immunogenic vaccine (Danish 1331), proper technique, experience of the vaccinator and good storage facilities available at our institute.


Asunto(s)
Vacuna BCG , Linfadenitis , Humanos , Lactante , Recién Nacido , Vacuna BCG/efectos adversos , Incidencia , Linfadenitis/epidemiología , Linfadenitis/etiología , Estudios Observacionales como Asunto , Estudios Prospectivos , Vacunación/efectos adversos
10.
Front Immunol ; 13: 958473, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-36203600

RESUMEN

Background: Reports of periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome from developing countries are sparse. Recognizing PFAPA is often challenging in these regions due to a higher incidence of infectious illnesses and significant resource constraints. Herein, we present our experience from North India regarding the diagnosis and management of PFAPA syndrome. Methods: We reviewed cases of non-monogenic periodic fever syndrome diagnosed at our center from January 2011 to December 2021. A total of 17 children who fulfilled the Marshall criteria for PFAPA syndrome were included. Data regarding basic clinical features, treatment/outcome, and performance of the recently proposed Eurofever/PRINTO and Takeuchi criteria were analyzed. Results: Besides recurrent fever, the triad of oral aphthae, pharyngitis, and adenitis was noted in only 18% of patients. Episodes of exudative pharyngitis/tonsillitis were documented in 24%. These figures were lower than the values reported from developed countries. The Takeuchi and Eurofever/PRINTO criteria were fulfilled in 76% and 71% cases, respectively. In addition to antipyretics and supportive care, intermittent steroid therapy was the main treatment modality used. Additional treatment with colchicine (n = 3) and thalidomide (n = 1) was used successfully in a few patients. Before the diagnosis of PFAPA, all patients had received multiple courses of antimicrobials (without microbiological confirmation). These included multiple courses of antibacterials for fever, pharyngotonsillitis, and/or cervical adenitis in all patients and antivirals for fever and aphthous stomatitis in a patient. Empiric antitubercular therapy had also been administered in two patients. Conclusions: A significant proportion of patients with PFAPA seem to remain undiagnosed in the Indian subcontinent. Increased awareness and improvement in basic healthcare facilities are crucial in enhancing the recognition of PFAPA, which would eliminate the unprecedented scale of undesirable antimicrobial use in such children.


Asunto(s)
Antipiréticos , Linfadenitis , Faringitis , Estomatitis Aftosa , Tonsilitis , Antivirales , Niño , Colchicina , Países en Desarrollo , Fiebre/diagnóstico , Fiebre/tratamiento farmacológico , Humanos , Linfadenitis/diagnóstico , Linfadenitis/tratamiento farmacológico , Linfadenitis/epidemiología , Faringitis/diagnóstico , Faringitis/tratamiento farmacológico , Esteroides , Estomatitis Aftosa/diagnóstico , Estomatitis Aftosa/tratamiento farmacológico , Estomatitis Aftosa/epidemiología , Síndrome , Talidomida
11.
Pediatr Int ; 64(1): e15294, 2022 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-36134651

RESUMEN

BACKGROUND: Periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome is an autoinflammatory disease occurring in children. Although PFAPA is the most common periodic fever syndrome found in children, there are only a few studies defining the clinical characteristics and the efficacy of treatment strategies among Japanese children. This study aimed to clarify the demographic characteristics and clinical features of patients with PFAPA syndrome and to evaluate treatment efficacy. METHODS: We retrospectively reviewed the clinical features of children with PFAPA who visited Saitama Children's Medical Center between January and December 2019. We also evaluated treatment strategies and their efficacy; abortive treatment with corticosteroids, prophylaxis with cimetidine or colchicine, and surgical management with tonsillectomy. RESULTS: A total of 100 Japanese children (61% male) with PFAPA were included. Median age of onset was 3 years, median duration of fever episodes was 5 days, and median interval between episodes was 4 weeks. The symptoms (frequencies) were pharyngitis (89%), exudate on tonsils (71%), cervical adenitis (50%), and aphthous stomatitis (49%). Approximately 37% of patients took prednisolone for aborting fever attacks, showing a 100% response; 93% were treated with cimetidine, showing an 79.6% response, and 18% were treated with colchicine, showing a 66.7% response. Only one patient underwent tonsillectomy. CONCLUSIONS: Among Japanese children with PFAPA, 28% of them were ≥5 years with a male predominance. Pharyngitis is the most frequent symptom associated with fever. Cimetidine is suitable for initial therapy because of its safety and efficacy.


Asunto(s)
Linfadenitis , Linfadenopatía , Faringitis , Estomatitis Aftosa , Tonsilectomía , Niño , Cimetidina/uso terapéutico , Colchicina/uso terapéutico , Femenino , Fiebre/complicaciones , Fiebre/etiología , Humanos , Recién Nacido , Japón/epidemiología , Linfadenitis/diagnóstico , Linfadenitis/epidemiología , Linfadenitis/terapia , Linfadenopatía/complicaciones , Masculino , Faringitis/complicaciones , Faringitis/diagnóstico , Faringitis/terapia , Prednisolona , Estudios Retrospectivos , Estomatitis Aftosa/diagnóstico , Estomatitis Aftosa/epidemiología , Estomatitis Aftosa/terapia , Síndrome , Resultado del Tratamiento
12.
Pediatr Rheumatol Online J ; 20(1): 82, 2022 Sep 15.
Artículo en Inglés | MEDLINE | ID: mdl-36109811

RESUMEN

BACKGROUND: Periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome is generally regarded as the most common autoinflammatory disease, but the epidemiology of the disease is largely unknown. The objectives of this study were to estimate the annual incidence and describe the clinical features of PFAPA in a large cohort from western Sweden. METHODS: The study retrospectively included children < 18 years of age diagnosed with PFAPA between 2006 and 2017 at three hospitals: NU Hospital Group, Skaraborg Hospital and Queen Silvia Children's Hospital. Patients were identified by searching for relevant diagnostic ICD-10 codes in the comprehensive electronic medical records and data were retrieved by reviewing case records. To estimate incidence, patients with symptom onset from January 1, 2006, to December 31, 2016, were included. Population data for the study area during this period were retrieved from Statistics Sweden. RESULTS: In this study, 336 patients with PFAPA were identified. Of these, 156 (46%) were girls and 180 (54%) were boys. Almost 90% of the children with PFAPA (291 patients) experienced their first symptoms before the age of 5 years and fewer than 3% presented at ages above 10 years. Pharyngitis was the most common symptom during febrile episodes, followed by cervical adenitis and aphthous stomatitis. Fourteen percent of the patients displayed atypical features, of which skin rash was the most common. To calculate incidence, 251 patients with symptom onset during the study period were identified. The mean annual incidence was estimated at 0.86/10,000 for children < 18 years of age and 2.6/10,000 for children < 5 years of age. CONCLUSIONS: This study adds to the understanding of the epidemiology of PFAPA syndrome by presenting incidence rates based on a large cohort and in different age groups in a population-based setting. It also shows the distribution of age of onset of PFAPA, with a peak in 1-year-olds and waning at older ages. Signs and symptoms of PFAPA syndrome were similar in children with symptom onset before vs. after 5 years of age.


Asunto(s)
Linfadenitis , Linfadenopatía , Faringitis , Estomatitis Aftosa , Niño , Preescolar , Femenino , Fiebre/diagnóstico , Fiebre/epidemiología , Humanos , Linfadenitis/diagnóstico , Linfadenitis/epidemiología , Masculino , Faringitis/diagnóstico , Faringitis/epidemiología , Estudios Retrospectivos , Estomatitis Aftosa/diagnóstico , Estomatitis Aftosa/epidemiología , Suecia/epidemiología , Síndrome
13.
Vet Med Sci ; 8(3): 1211-1218, 2022 05.
Artículo en Inglés | MEDLINE | ID: mdl-35120279

RESUMEN

BACKGROUND: Caseous lymphadenitis (CLA) is a chronic bacterial infectious disease that affects cattle, shoats, and other domestic and wild ruminants. METHODS: A purposive cross-sectional study was conducted on 30 cattle with enlarged lymph nodes to investigate CLA using cytopathological and bacteriological techniques from cattle slaughtered at Bishoftu municipal abattoir. RESULTS: From a total of 30 cattle subjected to clinical and post-mortem examinations, only one bull was found to be infected with a rare case of CLA in Bishoftu municipal abattoir, Ethiopia. Enlargement of the pre-scapular lymph node was the only clinical finding during ante-mortem inspection of the bull. The gross pathological lesion showed a pre-scapular lymph node with a caseo-necrotic dystrophic calcification that was accompanied by a rough texture and white to grayish hue. Histopathologically, the lymph node was characterized by central liquefactive necrosis that was surrounded by coagulative necrosis containing multiple foci of mineralization, infiltration of polymorphonuclear neutrophils and mononuclear immature fibrosis containing inflammatory cells and also with some sort of a thick layer of mature fibrosis that defines the magnitude of the lesion. Cytologically, multi-lobulated (intact and degenerated) neutrophils, a few reactive lymphocytes, macrophages and some crenated histocytes have been recognized. The bacterial culture of the sample revealed small, white cream, dry, waxy colonies with a narrow area of ß-haemolysis. The isolate of the sample was a Gram-positive cocci-bacilli that was arranged in a Chinese pattern on Gram staining, and catalase and urease were positive in the biochemical analysis of this organism, which was able to ferment glucose and maltose but not trehalose and xylose. CONCLUSIONS: The present investigation indicated that CLA was prevalent as sporadic cases among cattle slaughtered in Bishoftu municipal abattoir. Thus, effective preventive and control measures, such as good sanitation and hygiene, should be followed during meat inspection.


Asunto(s)
Infecciones por Corynebacterium , Linfadenitis , Mataderos , Animales , Bacterias , Bovinos , Infecciones por Corynebacterium/veterinaria , Estudios Transversales , Etiopía/epidemiología , Fibrosis , Linfadenitis/epidemiología , Linfadenitis/microbiología , Linfadenitis/veterinaria , Masculino , Necrosis/veterinaria
14.
Zhonghua Yu Fang Yi Xue Za Zhi ; 56(1): 38-43, 2022 Jan 06.
Artículo en Chino | MEDLINE | ID: mdl-35092989

RESUMEN

Objective: To investigate the economic burden of bacillus Calmette-Guérin (BCG) lymphadenitis in Shandong Province. Methods: From May 2011 to December 2019, 304 patients applying for the province-level compensation of BCG lymphadenitis was selected from Shandong Province in this study. The basic situation, vaccination, outpatient (inpatient) records, cost and relevant information of those patients were collected to calculate the direct economic burden (including direct medical costs and direct non-medical costs), indirect economic burden and total economic burden. Comparison of the difference of economic burden of cases with different characteristics was taken. Results: The M(Q1,Q3) of age of BCG lymphadenitis patients was 3 (2, 4) months, among which 239 cases (78.6%) were male, 71 cases (23.4%) had lymphadenopathy, and 227 cases (74.7%) underwent surgery.The number of outpatient only, inpatient only and outpatient then inpatient was 25.7% (78 cases), 7.2% (22 cases) and 67.1% (204 cases), respectively. The M(Q1,Q3) of direct, indirect and total economic burden of single case after discount was 9 910 (5 713, 16 074), 2 081 (1 547, 3 122) and 12 262 (7 694, 18 571) yuan, respectively.The direct medical expenses accounted for 89.4% of the direct economic burden, the direct economic burden accounted for 84.9% of the total economic burden, the total economic burden of 80.0% cases accounted for only about 20.0% of the compensation amount, and the total economic burden of only 2.3% cases accounted for more than 60.0% of the compensation amount.The direct, indirect and total economic burden of patients with inpatient only and outpatient then inpatient was higher than that of patients with outpatient only; the direct, indirect and total economic burden of patients with operation was higher than that of patients with non-operation; the direct and total economic burden of patients with unulcerated lymph node was higher than that of patients with ulcerated lymph node(all P values<0.05). Conclusion: The economic burden of BCG lymphadenitis cases in Shandong Province is influenced by the mode of diagnosis and treatment, with direct medical expenses as the predominant component.


Asunto(s)
Vacuna BCG , Linfadenitis , Costo de Enfermedad , Estrés Financiero , Humanos , Lactante , Linfadenitis/epidemiología , Masculino , Vacunación
15.
Hum Vaccin Immunother ; 18(1): 1938922, 2022 12 31.
Artículo en Inglés | MEDLINE | ID: mdl-34156902

RESUMEN

Although the administration of the Bacillus Calmette-Guérin (BCG) vaccine is generally safe, lymphadenitis, the most common complication of BCG vaccination, can occur. Here, we describe the epidemiological characteristics and incidence trends of BCG lymphadenitis in Shanghai, China, among a population with a high burden of tuberculosis. A total of 56 cases of adverse events following immunization (AEFI) after BCG vaccination were reported in Shanghai, including 51 cases of BCG lymphadenitis (91.07%), from 2010 to 2019. The general incidence of BCG lymphadenitis was 173 per 1,000,000 doses in Shanghai from 2010 to 2019. A nonsignificant increase of 58.81% per year was observed between 2010 and 2012 (t = 0.93; p = .40), followed by a significant decline of 28.00% per year from 2012 to 2019 (t = -4.27; p < .01). Seven batches of BCG vaccines triggered three or more BCG lymphadenitis cases, for 27 (52.94%) cases in total. We identified two patients with immunodeficiency of chronic granulomatous disease, one of whom died four years later after BCG vaccination and another of whom was still being treated after two transplants. The average total care cost of the 47 recovered cases was 11,336 RMB (range: 2,637-33,861 RMB). Due to the high burden of BCG lymphadenitis, especially in children with immunodeficiency, it is suggested that government departments should strengthen healthcare provider training, assign specific nurses to perform BCG vaccination, monitor vaccinated individuals actively and timely detect abnormal signals so as to reduce the incidence of BCG lymphadenitis.


Asunto(s)
Síndromes de Inmunodeficiencia , Linfadenitis , Mycobacterium bovis , Tuberculosis , Vacuna BCG , Niño , China/epidemiología , Humanos , Síndromes de Inmunodeficiencia/complicaciones , Lactante , Linfadenitis/inducido químicamente , Linfadenitis/epidemiología , Tuberculosis/prevención & control , Vacunación/efectos adversos
16.
Anim Biotechnol ; 33(7): 1655-1660, 2022 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-34028337

RESUMEN

Caseous lymphadenitis (CLA) is a chronic and insidious disease that mainly affects small ruminants and caused by Corynebacterium pseudotuberculosis (C. pseudotuberculosis). The aims of this research were to identify C. pseudotuberculosis by PCR from pyogenic lesions, to study the phylogenetic analysis of C. pseudotuberculosis and to detect the prevalence based on the detected superficial lesions of CLA in Dakahlia governorate, Egypt. Out of 3471 clinically examined animals, 129 (3.71%) animals were affected with CLA. The isolation rate of C. pseudotuberculosis in abscess of sheep was 45.74% (59/129). Out of 129 samples examined by PCR assay, 63 (48.83%) were positive phospholipase D (PLD) indicated at fragment size 203 bp. This is the first phylogenetic analysis study of C. pseudotuberculosis isolate in Egypt which was isolated from infected sheep. Nucleotide sequence identity data demonstrated that C. pseudotuberculosis PLD gene (MW187942) Dakahlia share homology 99.01%, 98.83 and 98.48% with Zagazig, Egypt (MN867024), Tamil nadu, India (MG720636) and Sudan (MG692441), respectively. In conclusion, this study provided information on the molecular detection and phylogeny of C. pseudotuberculosis in Egypt. Findings of this study can be conducted in other CLA endemic countries with similar animal breeding practices in the Middle East and developing countries.


Asunto(s)
Infecciones por Corynebacterium , Linfadenitis , Enfermedades de las Ovejas , Ovinos , Animales , Egipto/epidemiología , India , Filogenia , Enfermedades de las Ovejas/epidemiología , Linfadenitis/epidemiología , Linfadenitis/veterinaria , Linfadenitis/diagnóstico , Infecciones por Corynebacterium/epidemiología , Infecciones por Corynebacterium/veterinaria , Infecciones por Corynebacterium/microbiología
17.
Asian Pac J Cancer Prev ; 22(10): 3203-3210, 2021 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-34710996

RESUMEN

OBJECTIVE: This study aimed to assess the correlation between the genotyping of interleukin-10 (IL-10 polymorphism rs 1800871) and the incidence hepatocellular carcinoma (HCC) among patients with hepatitis C virus (HCV) treated with direct acting antivirals (DAAs). METHOD: For 200 patients with HCV infection who completed DAA treatment and followed up for 1 year, IL-10 polymorphism SNP(-819) rs 1800871 analysis was conducted via real time polymerase chain reaction. During the follow-up period, 100 patients who developed HCC were selected and compared with 100 patients who did not develop any complications. RESULTS: The studied patients were divided into two groups according to the incidence of complications after completion of DAA treatments. During the follow-up, 100 patients with HCV infection who developed HCC were selected and compared with 100 patients with HCV infection who did not develop any complications (positive control group). For the HCC group (n = 100), the mean age was 58.1 ± 6.4 years, with 92.7% being male and 7.3% being female; 91% had cirrhosis, 10% had lymphadenitis, 75% had splenomegaly, and 17% had ascites. In the positive control group (n = 100), mean age was 46.3 ± 9.4 years, with 68% being male and 32% being female; 20% had cirrhosis, 12% had splenomegaly, and 4.2% had ascites. The results demonstrated that sofosbuvir (SOF) + daclatasvir + ribavirin regimen was the most prevalent drug treatment for patients with HCC (72%), while SOF + Simeprevir was the most safe treatment for HCV infection among patients with HCC (2%). CT genotype was the most common genotype in the HCC group (56%), among different drug regimen (67.8%). T allele was the most prevalent in HCC group (61%), while the C allele was the least prevalent (39%). CONCLUSION: IL-10 genotyping may help in selecting the safest and most accurate drug regimen according to the safest genotype response relationship and follow-up of genotype resistance.


Asunto(s)
Antivirales/uso terapéutico , Carcinoma Hepatocelular/genética , Hepatitis C Crónica/tratamiento farmacológico , Interleucina-10/genética , Neoplasias Hepáticas/genética , Polimorfismo de Nucleótido Simple , Adulto , Anciano , Ascitis/epidemiología , Carbamatos/uso terapéutico , Carcinoma Hepatocelular/virología , Quimioterapia Combinada/métodos , Femenino , Hepacivirus , Hepatitis C Crónica/complicaciones , Humanos , Imidazoles/uso terapéutico , Cirrosis Hepática/epidemiología , Neoplasias Hepáticas/virología , Linfadenitis/epidemiología , Masculino , Persona de Mediana Edad , Pirrolidinas/uso terapéutico , Ribavirina/uso terapéutico , Simeprevir/uso terapéutico , Sofosbuvir/uso terapéutico , Esplenomegalia/epidemiología , Valina/análogos & derivados , Valina/uso terapéutico
18.
Ethiop J Health Sci ; 31(3): 653-662, 2021 May.
Artículo en Inglés | MEDLINE | ID: mdl-34483623

RESUMEN

BACKGROUND: Tuberculosis and human immunodeficiency virus (HIV) are among the major health problems in Ethiopia. This study assessed the proportion of tuberculosis lymphadenitis (TBLN), HIV infection and their co-infection among TBLN presumptive individuals at the selected hospitals in Northwest Ethiopia. METHODS: Institution based cross sectional study was carried out. Data on demographic and clinical variables were collected with standardized questionnaire. Microbiological culture was done on specimen obtained by fine needle aspirates. The HIV status was determined by rapid anti-HIV antibody test. Data was entered and scrutinized using SPSS version 20 statistical packages. A stepwise logistic regression model was used. The result was considered as statistically significant at P<0. 05. RESULTS: A total of 381 lymphadenitis patients were included in the study. The overall prevalence of TBLN and HIV were at 250(65.6%) and 9(2.4%), respectively and their co-infection was at 6(2.4%). Based on the cytological examination, 301(79.0%) of them were diagnosed as TBLN. The age group, (P=0.01) and residency, (P=0.01) were found significantly associated with TBLN. Similarly, unsafe sex was also statistically significant for HIV infection (P=0.007). CONCLUSION: Tuberculosis lymphadenitis is the leading cause of TB and lymphadenitis in the region. However, TBLN-HIV coinfection was promisingly low. High rate of discrepancy was noticed between cytological and culture results. Hence, the TBLN diagnostic criteria shall pursue revision.


Asunto(s)
Coinfección , Infecciones por VIH , Linfadenitis , Mycobacterium tuberculosis , Tuberculosis Ganglionar , Coinfección/epidemiología , Estudios Transversales , Etiopía/epidemiología , VIH , Infecciones por VIH/complicaciones , Infecciones por VIH/epidemiología , Humanos , Linfadenitis/epidemiología , Linfadenitis/etiología , Tuberculosis Ganglionar/epidemiología
20.
PLoS One ; 16(6): e0252893, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34101753

RESUMEN

Caseous lymphadenitis (CLA) or pseudotuberculosis is a chronic zoonotic bacterial disease caused by Corynebacterium pseudotuberculosis, which affects livestock and humans. This study aimed to describe the pathology, bacteriology and confirm the identity of the pathogen by 16S rRNA gene sequencing in Camelus dromedarius. A total of 12 camels with suspected CLA in three regions of Abu Dhabi Emirate (Abu Dhabi, Al Ain and Al Dhafra), United Arab Emirate (UAE) were subjected to clinical and postmortem examinations from January 2015 to December 2020. Clinically, camels were emaciated and showed the presence of external caseous abscesses suggestive of CLA. Postmortem examination showed multiple abscesses of variable sizes with caseous material encapsulated by fibrous tissue in the liver, lungs, muscle, and lymph nodes. Following clinical and postmortem examination, blood, pus and different tissue samples were collected for subsequent analysis. Histopathological examination of all organs stained with Hematoxylin and Eosin (H&E) indicated a central caseo-necrotic core that was admixed with bacterial colonies and infiltration of chronic inflammatory cells, surrounded by a pyogenic membrane, and an outer fibrous connective tissue capsule. Bacterial culture identified the isolates of Corynebacterium pseudotuberculosis biotype ovis strain, and these isolates were shown to be sensitive to all antibiotics tested (penicillin, ampicillin, Co-trimoxazole, enrofloxacin and tetracycline). Moreover, the identity of the isolates was confirmed by partial sequencing of the 16S rRNA gene which showed a 100% identity to Corynebacterium pseudotuberculosis. Phylogenetic analysis based on 16S rRNA gene sequence clearly differentiates Corynebacterium pseudotuberculosis from other species of Corynebacterium. Briefly, this study provided the basic information for infection of Corynebacterium pseudotuberculosis in Camels and will help in controlling of this pathogen in the region.


Asunto(s)
Enfermedades de los Animales/epidemiología , Infecciones por Corynebacterium/complicaciones , Corynebacterium/aislamiento & purificación , Linfadenitis/veterinaria , Enfermedades de los Animales/microbiología , Enfermedades de los Animales/patología , Animales , Antibacterianos/administración & dosificación , Camelus , Infecciones por Corynebacterium/tratamiento farmacológico , Infecciones por Corynebacterium/microbiología , Femenino , Linfadenitis/epidemiología , Linfadenitis/microbiología , Linfadenitis/patología , Masculino , Factores de Tiempo , Emiratos Árabes Unidos/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA